Skip to main content
. Author manuscript; available in PMC: 2021 May 1.
Published in final edited form as: Ann Neurol. 2020 Feb 27;87(5):700–709. doi: 10.1002/ana.25702

TABLE 1.

Participant Characteristics and Samples Available for Each Assay

Characteristic Control, n = 7 Sleep-Deprived, n = 7 Drug, n = 6
Age, yr
 Mean 47.6 48.1 51
 SD 9.2 10 9.8
Sex, M/F 2/5 3/4 3/3
Race, C/AA 3/4 3/4 2/4
Samples Available for Each Assay
Participant Control Sleep-Deprived Drug
Tau/p-tau α-synuclein pS129-α-synuclein Tau/p-tau α-synuclein pS129-α-synuclein Tau/p-tau α-synuclein pS129-α-synuclein
1 X X X BLD X X X BLD X X X BLD
2 X X X BLD X X X BLD X X X BLD
3 X X X X X X X X X X X X
4 X X X BLD X X X BLD X X X BLD
5 X X X X
6 X X X BLD X X
7 X X X X X X X X
8 X X X X X X X X

AA = African American; Aβ = amyloid-β; BLD = below detection limit; C = Caucasian; F = female; M = male; p-tau = phosphorylated tau;